TMRW Life Sciences

TMRW Life Sciences

Private
New York City, New YorkHealthcare & Life Scienceshttps://tmrwlifesciences.com

Last Round

Series D

Jul 24, 2024

Total Funding Raised

$175M

Company Overview

TMRW Life Sciences is a fertility technology company that has developed an automated, software-guided platform for the management, tracking, and storage of frozen human eggs and embryos used in in-vitro fertilization (IVF). The company's technology, which is FDA-cleared, uses robotics and RFID-enabled labware to digitally identify, track, and monitor frozen specimens 24/7, aiming to reduce potential points of failure by 94% compared to traditional manual systems. Founded in 2018, TMRW partners with fertility clinics to provide a scalable solution that enhances safety, transparency, and accuracy in the cryo-management process. The company offers both on-site and off-site biorepository storage solutions.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment, Supply Chain Tracking, Warehouse Automation, EHR & EMR

Business Model

B2B

Customer Profile

Hardware + Subscription, Services & Consulting, Hardware Sales, Subscription SaaS

AI Layer

Non-AI

Keywords

fertility technologyfertility techIVF automationautomated cryo-managementIVF techcryogenic storagedigital specimen managementfemtechRFID trackingdigital chain of custodylab automationbiorepository servicescryopreservation automationoffsite cryostoragemedical device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

TMRW Life Sciences Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

TMRW Life Sciences Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series DJul 24, 2024
AngelDec 1, 2022
DebtApr 29, 2022
Series CJul 20, 2021
Series BDec 17, 2019
Series A
May 29, 2019

Key People

Founding team and executive leadership

Lori Batta

Chief Operating Officer

Executive Team

TMRW Life Sciences Investors

Notable investors and investment history

InvestorRounds
GVSeries D, Series C
5AM VenturesSeries C, Series B, Series D
Trinity CapitalDebt
Casdin CapitalSeries D, Series C
Leerink Transformation PartnersSeries D, Series C

TMRW Life Sciences Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

TMRW Life Sciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about TMRW Life Sciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range70
Year Founded2018
Last FundingJul 24, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.